# Comparative Effect of Nigella Sativa and Conventional Management for OSMF

> **NCT04476420** · PHASE3 · COMPLETED · sponsor: **Ziauddin University** · enrollment: 39 (actual)

## Conditions studied

- Oral Submucous Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** Nigella sativa oil
- **DRUG:** Betamethasone Valerate

## Key facts

- **NCT ID:** NCT04476420
- **Lead sponsor:** Ziauddin University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-11
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476420, "Comparative Effect of Nigella Sativa and Conventional Management for OSMF". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04476420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*